Login:
 
Barclay C. Assessing risk of VTE with combined oral contraceptives. Practitioner 2012; 256 (1748): 9-10

Assessing risk of VTE with combined oral contraceptives

25 Feb 2012Registered users

Combined oral contraceptive pills (COCPs) containing desogestrel, gestodene or drospirenone appear to confer double the risk of venous thromboembolism (VTE) compared with those containing levonorgestrel, a large population-based study has found. Data on all women in Denmark aged 15-49 years were identified from four national registries during the period 2001-2009. [With external links to the current evidence base]

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.